ClinicalTrials.gov
public full text
Public Domain
DURAFIBER Ag Post-Market Clinical Follow-Up
The aim of the study is to evaluate the performance of DURAFIBER Ag and to assess how many bacteria are present in infected wounds over an 8 week period.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Levilactobacillus Brevis Oral Health#1111640
- Prévalence, circulation et la caractérisation des bactéries à Gram négatif multirésistantes aux antibiotiques (BMR) chez et entre les hommes, les animaux et l’environnement par une approche one Health à Djibouti#254119
- Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)#141038
- Bacterial infections epidemiology and factors associated with multidrug resistance in the northern region of Ghana#144900
- Prevalence of Multi-Drug Resistant Bacteria in Long-term Care Facilities#373630
Record · ID 859616
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive